Literature DB >> 15891905

Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.

Shigeki Shiohara1, Tanri Shiozawa, Tsutomu Miyamoto, Yu-Zhen Feng, Hiroyasu Kashima, Miyuki Kurai, Akihisa Suzuki, Ikuo Konishi.   

Abstract

We previously reported the overexpression of cyclins in uterine cervical carcinoma; however, their clinicopathological significance remained undetermined. In the present study, we examined the immunohistochemical expression of cyclins (D1, E, A, B1), p53 and Ki-67 in squamous cell carcinoma (stage Ib+II; 80 cases, stage III+IV; 23 cases). Correlations between the expression of cyclins and clinicopathological parameters and patient survival were statistically evaluated. The results indicated that in the normal squamous epithelium, the expression of cyclins and Ki-67 was sporadically observed in the parabasal layer. Of the 103 cervical carcinomas, overexpression of cyclins D1, E, A, B1 and p53 was observed in 13 (13%), 23 (22%), 25 (24%), 18 (18%) and 23 (22%) cases, respectively, with a slight predominance in advanced stage tumors. The expression of cyclin D1, E, A and p53 significantly correlated with that of Ki-67 (Spearman's rank correlation). Univariate and multivariate analyses revealed that lymph node metastasis and cyclin A overexpression were independent prognostic factors for unfavorable outcomes in stage Ib+II patients. These findings suggest that the overexpression of various cyclins is involved in the acquisition of the vigorous growth potential of cervical carcinoma cells, and that cyclin A is an independent prognosticator of cervical carcinoma in early stages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891905     DOI: 10.1007/s00428-005-1252-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  42 in total

1.  Prognostic value of p53 expression in stage IB1 cervical carcinoma.

Authors:  H Y Chen; C T Hsu; W C Lin; H D Tsai; W C Chang
Journal:  Gynecol Obstet Invest       Date:  2000       Impact factor: 2.031

2.  MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy.

Authors:  K Oka; T Arai
Journal:  Int J Gynecol Pathol       Date:  1996-01       Impact factor: 2.762

3.  Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix.

Authors:  M Kanai; T Shiozawa; L Xin; T Nikaido; S Fujii
Journal:  Cancer       Date:  1998-05-01       Impact factor: 6.860

4.  A link between cyclin A expression and adhesion-dependent cell cycle progression.

Authors:  T M Guadagno; M Ohtsubo; J M Roberts; R K Assoian
Journal:  Science       Date:  1993-12-03       Impact factor: 47.728

5.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

6.  Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.

Authors:  Jung-Kuang Hsieh; Damian Yap; Daniel J O'Connor; Valentina Fogal; Lynn Fallis; Florence Chan; Shan Zhong; Xin Lu
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.

Authors:  D S Bae; S B Cho; Y J Kim; J D Whang; S Y Song; C S Park; D S Kim; J H Lee
Journal:  Gynecol Oncol       Date:  2001-06       Impact factor: 5.482

8.  Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.

Authors:  H Takeuchi; S Ozawa; N Ando; C H Shih; K Koyanagi; M Ueda; M Kitajima
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

9.  Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type.

Authors:  C Isacson; T D Kessis; L Hedrick; K R Cho
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

10.  Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix.

Authors:  S A Southern; C S Herrington
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

View more
  6 in total

1.  Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.

Authors:  Rolf Aamodt; Kristin Jonsdottir; Solveig Norheim Andersen; Johan Bondi; Geir Bukholm; Ida R K Bukholm
Journal:  Gastroenterol Res Pract       Date:  2009-12-15       Impact factor: 2.260

2.  Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.

Authors:  Yan Zhao; Huan Wang; Yang Yang; Wendan Jia; Tong Su; Yuxin Che; Yixin Feng; Xuemei Yuan; Xuelian Wang
Journal:  Int J Nanomedicine       Date:  2020-12-01

Review 3.  The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.

Authors:  Denghua Pan; Kanglai Wei; Yanxin Ling; Shitao Su; Meilin Zhu; Gang Chen
Journal:  Med Sci Monit       Date:  2015-03-25

4.  Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.

Authors:  Mona Mohamed El-Naa; Mohamed Othman; Sheren Younes
Journal:  Drug Des Devel Ther       Date:  2016-11-16       Impact factor: 4.162

5.  p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer.

Authors:  Shilei Wen; Jinhang Gao; Linhao Zhang; Hongying Zhou; Dingzhi Fang; Shi Feng
Journal:  Oncotarget       Date:  2016-11-15

6.  The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions.

Authors:  M I Zubillaga-Guerrero; B Illades-Aguiar; M A Leyva-Vazquez; E Flores-Alfaro; E Castañeda-Saucedo; J F Muñoz-Valle; L C Alarcón-Romero
Journal:  J Cytol       Date:  2013-01       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.